Idexx Laboratories Contract Assets, Non-Current increased by 1.7% to $240.96M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.9%, from $189.88M to $240.96M. Over 5 years (FY 2020 to FY 2025), Contract Assets, Non-Current shows an upward trend with a 20.9% CAGR.
An increase indicates strong long-term contract performance but may signal potential future cash flow delays, while a decrease suggests faster billing cycles.
This represents the company's right to consideration for goods or services transferred to a customer that are not yet bi...
Standard for SaaS companies with multi-year enterprise agreements and complex revenue recognition schedules.
contract_assets_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $106.96M | $114.67M | $122.16M | $131.01M | $138.78M | $141.49M | $148.97M | $152.21M | $157.82M | $159.20M | $167.96M | $173.43M | $180.17M | $185.86M | $185.51M | $189.88M | $206.88M | $216.78M | $236.91M | $240.96M |
| QoQ Change | — | +7.2% | +6.5% | +7.2% | +5.9% | +2.0% | +5.3% | +2.2% | +3.7% | +0.9% | +5.5% | +3.3% | +3.9% | +3.2% | -0.2% | +2.4% | +9.0% | +4.8% | +9.3% | +1.7% |
| YoY Change | — | — | — | — | +29.7% | +23.4% | +21.9% | +16.2% | +13.7% | +12.5% | +12.7% | +13.9% | +14.2% | +16.8% | +10.4% | +9.5% | +14.8% | +16.6% | +27.7% | +26.9% |